Clinical Trials in Atlanta

Showing 4841-4860 of 19,805 trials

Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain

NCT05506982

This phase I trial evaluates the side effects of psilocybin and how well it works under supportive care conditions in cancer survivors living with demoralization and chronic pain. Cancer patients often experience demoralization, which is characterized by feelings of hopelessness, loss of meaning, and existential distress. Psilocybin psychotherapy, together with multidisciplinary palliative and supportive care, may help treat the anxiety, depression, and chronic pain felt by cancer survivors - defined here as cancer patients from time of diagnosis through the end-of-life.

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Emory University11 participantsStarted Nov 2022

Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

NCT04924101

The purpose of this study is to evaluate the use of investigational agents (MK-4830, boserolimab (MK-5890) and lenvatinib (MK-7902)) in combination with pembrolizumab (MK-3475) and etoposide/platinum chemotherapy for the first-line treatment of participants with extensive-stage small cell Lung Cancer (ES-SCLC). No formal hypothesis testing will be performed for this study.

Small Cell Lung Cancer

Merck Sharp & Dohme LLC126 participantsStarted Jul 2021

Gilbert, Arizona, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +46 more locations

Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Find Trials by Condition in Atlanta

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Study Evaluating the Safety and Efficacy of AR-15512

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Secur-Fit Advanced Outcomes Study

A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

Non-surgical Spinal Decompression Therapy and Outcomes

Evaluation of Alcon Ladarvision Wavefront-Guided PRK